- Condition: Essential Hypertension
Interventions: Drug: XOMA 985; Drug: Amlodipine Besylate; Drug: Perindopril Erbumine
Sponsors: XOMA (US) LLC; XOMA (US) LLC
Recruiting - verified March 2012 - Conditions: Hypertension; Metabolic Syndrome
Intervention: Drug: Aliskerin/Valsartan and Rampiril
Sponsors: University of Michigan Health System; University of Michigan Health System; Novartis Pharmaceuticals
Recruiting - verified September 2011 - Conditions: Hypertension; Stage 2 Hypertension; Diabetes
Interventions: Drug: Valturna + amlodipine; Drug: valturna + placebo; Drug: Valturna + chlorthalidone
Sponsors: Novartis; Novartis
Recruiting - verified May 2012 - Condition: Cardiovascular Events
Interventions: Drug: Aliskiren and Amlodipine or HCTZ; Drug: Aliskiren; Drug: Amlodipine or HCTZ; Drug: Placebo
Sponsors: Novartis; Novartis; Population Health Research Institute
Recruiting - verified May 2012 - Conditions: Obesity; Hypertension
Interventions: Drug: eplerenone, amlodipine; Drug: eplerenone; Drug: eplerenone; Drug: amlodipine
Sponsors: University of Mississippi Medical Center; University of Mississippi Medical Center
Recruiting - verified April 2012


